[HTML][HTML] Blood cell activation in myeloproliferative neoplasms
F Cervantes, E Arellano-Rodrigo… - haematologica, 2009 - ncbi.nlm.nih.gov
F Cervantes, E Arellano-Rodrigo, A Alvarez-Larrán
haematologica, 2009•ncbi.nlm.nih.govMyeloproliferative neoplasms are characterized by overproduction of mature blood cells and
increased risk of thromboembolic complications. However, the molecular lesions associated
with these disorders also activate circulating blood cells. In this perspective article, Dr.
Cervantes and his colleagues examine the role of blood cell activation in the
pathophysiology of thrombosis in myeloproliferative neoplasms. See related article on page
1537.
increased risk of thromboembolic complications. However, the molecular lesions associated
with these disorders also activate circulating blood cells. In this perspective article, Dr.
Cervantes and his colleagues examine the role of blood cell activation in the
pathophysiology of thrombosis in myeloproliferative neoplasms. See related article on page
1537.
Abstract
Myeloproliferative neoplasms are characterized by overproduction of mature blood cells and increased risk of thromboembolic complications. However, the molecular lesions associated with these disorders also activate circulating blood cells. In this perspective article, Dr. Cervantes and his colleagues examine the role of blood cell activation in the pathophysiology of thrombosis in myeloproliferative neoplasms. See related article on page 1537.
ncbi.nlm.nih.gov